---

Heather Bresch

Chief Executive Officer, Mylan

Revenue: $7.7 billion (2014)
Employees: circa 30,000

Heather is responsible for a workforce of approximately 30,000, a manufacturing footprint comprising nearly 40 facilities, and a portfolio of roughly 1,400 products sold in about 145 countries and territories. She aims to lead the next chapter of Mylan’s growth by transforming it from a pharmaceutical company into a healthcare company. She is also a leading advocate for global competitiveness and global quality standards — she was instrumental in the development of the US Generic Drug User Fee Act.

www.mylan.com

---

Part of the Power List 2015

Who are the most influential medicine makers?

That’s the question we posed to ourselves – and then to you – over two months ago, ahead of open nominations and a painstaking judging process. Here, without further ado, we celebrate the answer.

Go to The Power List 2015